0001533914-20-000002.txt : 20200415 0001533914-20-000002.hdr.sgml : 20200415 20200415103700 ACCESSION NUMBER: 0001533914-20-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200415 DATE AS OF CHANGE: 20200415 EFFECTIVENESS DATE: 20200415 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OnKure, Inc. CENTRAL INDEX KEY: 0001533914 IRS NUMBER: 451451149 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-365012 FILM NUMBER: 20792924 BUSINESS ADDRESS: STREET 1: 1105 SPRUCE STREET CITY: BOULDER STATE: CO ZIP: 80302 BUSINESS PHONE: 720 307 2892 MAIL ADDRESS: STREET 1: 1105 SPRUCE STREET CITY: BOULDER STATE: CO ZIP: 80302 D 1 primary_doc.xml X0708 D LIVE 0001533914 OnKure, Inc. 1105 SPRUCE STREET BOULDER CO COLORADO 80302 720 307 2892 DELAWARE None None Corporation true Anthony D. Piscopio c/o OnKure, Inc. 1105 Spruce Street Boulder CO COLORADO 80302 Executive Officer Director Xuedong Liu 7007 Johnson Circle Niwot CO COLORADO 80503 Executive Officer Director Donna Peak 2 Longfellow Lane Houston TX TEXAS 77005 Director Zhao Guobao Suite 1907, Office Tower El, Oriental Plaza, No. 1, East Chang Ave, Dong Cheng Beijing F4 CHINA 100738 Director Keith Michael Olivia c/o OnKure, Inc. 1105 Spruce Street Boulder CO COLORADO 80302 Executive Officer John DeMattei c/o OnKure, Inc. 1105 Spruce Street Boulder CO COLORADO 80302 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2020-04-15 false true true true Series A-1 Preferred Stock, Common Stock and Warrants to purchase Series A-1 Preferred Stock false 12148 5236935 3236935 2000000 The total offering amount includes the cumulative exercise price of $2,000,000 for Warrants to purchase 928,820 shares of Series A-1 Preferred Stock. false 6 0 0 0 false OnKure, Inc. Keith M. Olivia Keith M. Olivia General Counsel 2020-04-15